Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT

Journal of Nutritional Biochemistry

Volumn 14, Issue 9, 2003, Pages 513-521

  Ciubotaru, Irina ^a   Lee, Ye Sun ^a   Wander, Rosemary C ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

C reactive protein; Fish oil; HRT; Interleukin 6; Triacylglycerol HDL cholesterol

Indexed keywords

C REACTIVE PROTEIN; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SAFFLOWER OIL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CELL CULTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; MEASUREMENT; NORMAL HUMAN; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; STIMULATION; SUPERNATANT; TIME; TRIACYLGLYCEROL BLOOD LEVEL;

CARTHAMUS TINCTORIUS;

EID: 0141737794     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(03)00101-3     Document Type: Article

References (50)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:(2):1999;115-126.
2. Ridker P.M., Buring J.E., Shih H., Hennekens C.H. Prospective study of C- reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 98:(8):1998;731-733.
3. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342:(12):2000;836-843.
4. Ridker, PM, Cushman, M, Stampfer, MJ, Tracy, RP, Hennekens, CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men [published erratum appears in N Engl J Med 1997 Jul 31;337(5):356]. N Engl J Med 1997;336(14):973-9.
5. Tracy R.P., Lemaitre R.N., Psaty B.M., Ives D.G., Evans R.W., Cushman M., Meilahn E.N., Kuller L.H. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1:(7):1997;1121-1127.
6. Knopp R.H. Risk factors for coronary artery disease in women. Am J Cardiol. 89:(12 suppl):2002;28E-35E.
7. Ridker P.M., Hennekens C.H., Rifai N., Buring J.E., Manson J.E. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 100:1999;713-716.
8. Hutchinson W.L., Koenig W., Frochlich M., Sund M., Lowe G.D.O., Pepys M.B. Immunoradiometric assay of circulating C-reactive protein age related values in adult general population . Clin Chem. 46:(7):2000;934-938.
9. Heilbronn L.K., Clifton P.M. C-reactive protein and coronary artery disease influence of obesity, caloric restriction and weight loss . J Nutr Biochem. 13:(6):2002;316-321.
10. Taaffe D.R., Harris T.B., Ferrucci L., Rowe J., Seeman T.E. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons MacArthur Studies of successful aging . J Geront. 55A:(12):2000;M709-M715.
11. Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta. 153:(1):1985;9-13.
12. Imhof A., Froehlich M., Brenner H., Boeing H., Pepys M.B., Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 357:2001;763-767.
13. Vickers M.A., Green F.R., Terry C., Mayosi B.M., Julier C., Lathrop M., Ratcliffe P.J., Watkins H.C., Keavney B. Genotype at the promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res. 53:(4):2002;1029-1034.
14. Berger P., McConnell J.P., Nunn M., Kornman K.S., Sorrell J., Stephenson K., Duff G.W. C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine. 17:(4):2002;171-174.
15. Zee R.Y., Ridker P.M. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis. 162:(1):2002;217-219.
16. Sharrett A.R., Sorlie P.D., Chambless L.E., Folsom A.R., Hutchinson R.G. Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence the Artherosclerosis Risk in Communities Study . Am J Epidemiol. 149:(9):1999;843-852.
17. Barber M.D. Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation. Nutrition. 17:(9):2001;751-755.
18. Schmidt E.B., Varming K., Ernst E., Madsen P., Dyeberg J. Dose response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost. 63:(1):1990;1-5.
19. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction the results of the GISSI Prevenzione trial . Lancet. 354:1999;447-455.
20. Wander R.C., Du S.H. Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids. Am J Clin Nutr. 7:(2):2000;731-737.
21. Wander R.C., Patton B.D. Comparison of three species of fish consumed as part of a Western diet effects on platelet fatty acids and function, homeostasis, and production of tromboxane . Am J Clin Nutr. 54:(2):1991;326-333.
22. Higdon J.V., Liu J., Du S.H., Morrow J.D., Ames B.N., Wander R.C. Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F(2)-isoprostanes. Am J Clin Nutr. 72:(3):2000;714-722.
23. El-Hamdy A.H., Perkins E.G. High performance reversed phase chromatography of natural triglyceride mixtures critical pair separation . J Am Oil Chem Soc. 5:(8):1991;867-872.
24. American Oil Chemists' Society. Method Cd-8-53. In Official Methods and Recommended Practices. American Oil Chemists' Society, Champaign, IL 1988; 8:-53.
25. Allain C.C., Poon L.S., Cahn C.S., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem. 20:(4):1974;470-475.
26. McGowan M.W., Artiss J.D., Strandbergh D.R., Zak B. A peroxidase-coupled method for colorimetric determination of serum triglycerides. Clin Chem. 29:(3):1983;538-542.
27. Marz W., Gross W. Evaluation of a phosphotungstic acid/MgCl2 precipitation and quantitative lipoprotein electrophoresis assay. Clin Chem. 160:(1):1986;1-18.
28. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:(6):1972;499-502.
29. Song J., Wander R.C. Effects of dietary selenium and fish oil (MaxEPA) on arachidonic acid metabolism and hemostatic function in rats). J Nutr. 12:(1):1991;284-292.
30. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Phys. 3:(7):1995;911-917.
31. Jamieson J. Dealing with baseline differences two principles and two dilemmas . Int J Psychophysiol. 31:(2):1999;155-161.
32. Fry, J. Biological data analysis. A Practical Approach/ edited by John C. Fry. Oxford; New York: IRL Press at Oxford University Press, 1993 [chapter 1].
33. Zar J.H. Biostatistical analysis, 3rd ed. 1996;Prentice Hall, New Jersey. chapter 13.
34. Bermudez E.A., Rifai N., Buring J., Manson J.E., Ridker P.M. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 22:(10):2002;1668-1673.
35. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed:1988;40 Lawrence Erlbaum Associates, Hillsdale, NY.
36. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., Erdman J.W. Jr, Kris-Etherton P., Goldberg I.J., Kotchen T.A., Lichtenstein A.H., Mitch W.E., Mullis R., Robinson K., Wylie-Rosett J., St Jeor S., Suttie J., Tribble D.L., Bazzarre T.L. AHA Dietary Guidelines revision 2000 . a statement for healthcare professionals from the Nutrition Committee of the American Heart Association Circulation. 102:(18):2000;2284-2299.
37. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. N Engl J Med. 316:(18):1987;1105-1110.
38. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative randomized controlled trial . JAMA. 288:(3):2002;321-333.
39. Herrington D.M., Brosnihan K.B., Pusser B.E., Seely E.W., Ridker P.M., Rifai N., MacLean D.B. Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women. J Clin Endocrinol Metab. 86:(9):2001;4216-4222.
40. Ridker P.M., Hennekens C.H., Rifai N., Buring J.E., Manson J.E. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 10:1999;713-716.
41. Stark K.D., Park E.J., Maines V.A., Holub B.J. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-contralled, double-blind trial. Am J Clin Nutr. 72:(2):2000;389-394.
42. Goudev A., Georgiev D., Koycheva N., Manasiev N., Kyurkchiev S. Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. Maturitas. 30:(1):2002;43-49.
43. Ranta V., Oksanen H., Arrenbrecht S., Ylikorkala O. National differences in lipid response to postmenopausal hormone replacement therapy. Maturitas. 42:(4):2002;259-265.
44. Harris W.S. n-3 fatty acids and serum lipoproteins human studies . Am J Clin Nutr. 65:1997;1645S-1654S.
45. Austin M.A., Hokanson J.E., Edwards K.L. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 81:(4A):1998;7B-12B.
46. Thompson B. "Statistical", "Practical", and "Clinical:" How many kinds of significance do counselors need to consider? J Counseling Development. 8:2002;64-71.
47. Ernst E., Saradeth T., Achhammer G. n-3 fatty acids and acute-phase proteins. Eur J Clin Invest. 21:(1):1991;77-82.
48. Wigmore S.J., Fearon K.C., Ross J.A. Modulation of human hepatocyte acute phase protein production in vitro by n-3 and n-6 polyunsaturated fatty acids. Ann Surg. 225:(1):1997;103-111.
49. Madsen T., Skou H.A., Hansen V.E., Fog L., Christensen J.H., Toft E., Schmidt E.B. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol. 88:(10):2001;1139-1142.
50. Chan D.C., Watts G.F., Barrett P.H., Beilin L.J., Mori T.A. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem. 48:(6 Pt 1):2002;877-883.